The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Medical Distribution
China National Accord Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.27% HKD14.60
America/New_York / 5 mai 2024 @ 21:41
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 19 491 mill |
| EPS: | 3.16 |
| P/E: | 4.62 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 1 335.00 mill |
| Avg Daily Volume: | 0.224 mill |
| RATING 2024-04-30 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.13x |
| Company: PE 4.62 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.08x |
| Company: PE 4.62 | industry: PE 57.23 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
HKD 14.33 - 14.79 ( +/- 1.59%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | HKD14.60 (0.27% ) |
| Volume | 0.0102 mill |
| Avg. Vol. | 0.224 mill |
| % of Avg. Vol | 4.55 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 200028.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
200028.SZ
China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.